Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Technology
  3. NASDAQ
  4. SONM

Market Cap: $4.7M

DI

DNA X, Inc.

SONM
NASDAQ (NASDAQ Capital Market)USD
Purchase SONM
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin48.37%
EBITDA Margin9.01%
EBIT Margin18.27%
Pre-tax Margin22.84%
Net Profit Margin30.62%
Earnings Yield-2.00%
Valuation Multiples
Price / Book-3.47
Price / Sales-0.17
Price / Earnings-2.49
PEG-0.01
Forward PEG-0.08
EV / Sales-0.22
Cash Flow & Capital
Free Cash Flow / Share-$10.81
Operating Cash Flow / Share-$10.74
Free Cash Flow Yield-3.10%
Capex / Revenue-0.34%
Capex / Operating Cash Flow-0.65%
Capex / Depreciation-0.05
Liquidity & Leverage
Current Ratio0.57
Quick Ratio0.57
Cash Ratio0.17
Debt / Assets0.53
Debt / Capital2.05
Debt / Equity-1.95
Efficiency & Working Capital
Asset Turnover-6.18
Fixed Asset Turnover0.00
Inventory Turnover0.00
Receivables Turnover-22.10
Payables Turnover-21.10
Days Sales Outstanding-16.52
Returns & Quality
Return on Equity3.91%
Return on Assets-1.89%
Return on Invested Capital-2.28%
ROCE6.67%
Return on Tangible Assets-2.72%
Operating Return on Assets-90.11%
Balance Sheet & Intrinsic Metrics
Enterprise Value$6.2M
Invested Capital$-848K
Working Capital$-2.23M
Tangible Asset Value$-2.61M
Net Current Asset Value$-2.83M
Graham Net-Net
Financial Health Scores
Piotroski Score0
Altman Z-Score-102.65
Revenue$-27.91M
EBIT$-5.1M
Market Cap$4.72M
Working Capital$-2.23M
EV / EBITDA
-2.47
EV / Operating Cash Flow-0.43
EV / Free Cash Flow-0.42
Price / Free Cash Flow-0.32
Price / Operating Cash Flow-0.29
Stock Compensation / Revenue2.92%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Long-Term Debt / Capital
0.00
Debt / Market Cap51.03%
Net Debt / EBITDA-0.60
Solvency Ratio-1.04
Financial Leverage-3.67
Days Inventory Outstanding0
Days Payables Outstanding-17.3
Operating Cycle-16.52
Cash Conversion Cycle0.78
Working Capital Turnover17.20
Income Quality-1.20
Tax Burden1.34
Interest Burden1.25
-$2.89
Book Value / Share-$0.91
Tangible Book Value / Share-$1.93
Cash / Share$0.67
Retained Earnings
$-298.91M
Total Assets$4.52M
Total Liabilities$5.75M